Cargando…
Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
SIMPLE SUMMARY: Up to 90% of bladder cancers originate from the cells that line the interior of the bladder and are called urothelial carcinomas (UC). Faster growth of UC leads to a higher demand for nutrients and energy than non-malignant cells. UC compensates for this high demand for energy and bu...
Autores principales: | Scholtes, Mathijs P., de Jong, Florus C., Zuiverloon, Tahlita C. M., Theodorescu, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830378/ https://www.ncbi.nlm.nih.gov/pubmed/33466735 http://dx.doi.org/10.3390/cancers13020288 |
Ejemplares similares
-
Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
por: Zuiverloon, Tahlita C.M., et al.
Publicado: (2018) -
Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer
por: de Jong, Florus C., et al.
Publicado: (2021) -
Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer(1)
por: Tu, Megan M., et al.
Publicado: (2019) -
Biomarker-Oriented Therapy in Bladder and Renal Cancer
por: Scholtes, Mathijs P., et al.
Publicado: (2021) -
Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring?
por: de Jong, Florus C., et al.
Publicado: (2023)